dc.contributor.author
Fares Otero, Natalia Elena
dc.contributor.author
Leucht S
dc.contributor.author
Seedat S
dc.date.accessioned
2026-02-28T19:09:09Z
dc.date.available
2026-02-28T19:09:09Z
dc.date.issued
2026-02-27T10:20:09Z
dc.date.issued
2026-02-18
dc.date.issued
2026-02-26T09:57:23Z
dc.date.issued
info:eu-repo/date/embargoEnd/2026-08-18
dc.identifier
Fares N; Leucht S; Seedat S (2026). Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.. Lancet Psychiatry, (), S2215-8. DOI: 10.1016/S2215-0366(26)00025-8
dc.identifier
https://hdl.handle.net/2445/227620
dc.identifier.uri
https://hdl.handle.net/2445/227620
dc.description.abstract
Schizophrenia spectrum disorders (SSD) are among the leading global causes of disability, owing to chronic trajectories and high rates of treatment resistance. Antipsychotic medications are generally effective, but in up to a third of individuals with an acute episode, their symptoms show insufficient treatment response, underscoring the need to identify predictors of poor outcomes.
dc.format
application/pdf
dc.relation
https://doi.org/10.1016/S2215-0366(26)00025-8
dc.relation
Lancet Psychiatry, 2026, S2215-8
dc.relation
https://doi.org/10.1016/S2215-0366(26)00025-8
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/embargoedAccess
dc.subject
Biological psychiatry
dc.subject
Ciências biológicas ii
dc.subject
Engenharias iv
dc.subject
General medicine
dc.subject
Psychiatry and mental health
dc.subject
Saúde coletiva
dc.title
Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.
